Article Details
Retrieved on: 2024-11-27 21:28:13
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses Roche's experimental biopharma drug tiragolumab, which targets TIGIT in cancer immunotherapy, failing a major lung cancer study. The study links to key concepts of the PD-1 protein and lung cancer treatments.
Article found on: www.statnews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here